Surrozen, Inc./DE (SRZN) Form 10-Q — Aug 6, 2026
Surrozen filed its Q2 2026 10-Q reporting $5.0 million of collaboration revenue and $50.2 million of quarterly net income, but the profit came almost entirely from $59.6 million of noncash gains on remeasuring its PIPE tranche and warrant liabilities; the first half still produced a $77.3 million net loss. The balance sheet shows $102.0 million of cash against a $604.6 million accumulated deficit and a $218.7 million stockholders' deficit, with operating cash burn accelerating to $19.9 million in the half. Management affirmed a runway of at least 12 months but said it anticipates needing to raise additional capital.
Key figures
- Eps
- Q2 2026 basic $2.75 / diluted $(0.41); 1H 2026 basic $(6.84)
- Revenue
- 5000000
- Net Income
- Q2 2026 net income $50.2 million (noncash-driven); 1H 2026 net loss $77.3 million
- Total Assets
- 115606000
- Cash Position
- 102039000
- Shares Outstanding
- 11753558
- H1 2026 revenue
- 10000000
- Total liabilities
- 334271000
- Tranche liability
- 196269000
- Ga expense q2 2026
- 6886000
- Accumulated deficit
- 604613000
- Rnd expense q2 2026
- 8484000
- Warrant liabilities
- 124663000
- Potential dilutive shares excluded
- 21974000
- Contingent pipe second tranche gross
- 95100000
- Q2 noncash fv gains tranche and warrants
- 59600000
Price after filing
Close on the filing date to close N calendar days later (from $22.00). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.